Visningssätt för begreppens/termernas förhållanden:
Det sätt begreppsrelationer visas:
Det sätt begreppsrelationer visas:
Leukotriener
Hierarki: | ∟ ∟ ∟ ∟ ∟ ∟ Leukotriener 10 sidobegrepp4 underordnad begrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Leukotriener 10 sidobegrepp4 underordnad begrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Leukotriener 10 sidobegrepp4 underordnad begrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Leukotriener 10 sidobegrepp4 underordnad begrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Leukotriener 10 sidobegrepp4 underordnad begrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Leukotriener 10 sidobegrepp4 underordnad begrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ |
Bredare villkor: | |
Snävare villkor: | |
Anmärkning: | |
Anmärkning: | A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system.
X |
Annotation: | eicosanoids; GEN or unspecified; prefer specifics; /biosyn /physiol permitted
X |
historyNote*: | 89
X |
publicMeSHNote*: | 89
X |
activeMeSHYear*: | |
dateCreated*: | 1988-05-24X |
dateEstablished*: | 1989-01-01X |
dateRevised*: | 2005-06-30X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | ssbX |
recordOriginator*: | RLSX |
Relaterad term: | |
Typ: | |
Samordna villkor: | |
URI: | |
Termer och motsvarande begrepp: | Leukotrieenit (fi) XLeukotrieeni (fi, ersatt) Leukotrienes (en) |
Dela: |
Laddar resultat...